Contributors: View
Ross Weatherman

| Contributions | 1 (detailed usage) |
|---|---|
| Affiliation | Purdue University, West Lafayette |
| Web Site | http://www.mcmp.purdue.edu/faculty/?uid=rossw |
| Biography | Ross Weatherman is currently an assistant professor in the Department |
Contributions
-
Antiestrogenic Conjugates as New Breast Cancer Chemoprevention Agents
- This resource has a 6.2 Ranking
-
Ranking is calculated from a formula comprised of user reviews and usage statistics. Learn more ›
Usage Stats Last 12 Months: updated 01 Jun, 2008 Users: 26 Reviews & Citations Google/IEEE Avg. Review: Citations: 0
26 users
08 Mar. 2007 | Online Presentations | Contributor(s): Ross Weatherman
Tamoxifen is the first drug specifically approved for the prevention of cancer and arguably the most successful anticancer drug of all time. Although millions of breast cancer patients have benefited from tamoxifen therapy, there are side effects that hinder the broad use of tamoxifen as a …